Capricor
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Capricor and other ETFs, options, and stocks.About CAPR
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine.
CEOLinda Marbán
CEOLinda Marbán
Employees160
Employees160
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded1996
Founded1996
Employees160
Employees160
CAPR Key Statistics
Market cap431.48M
Market cap431.48M
Price-Earnings ratio-6.65
Price-Earnings ratio-6.65
Dividend yield—
Dividend yield—
Average volume4.60M
Average volume4.60M
High today$9.94
High today$9.94
Low today$9.07
Low today$9.07
Open price$9.59
Open price$9.59
Volume3.27M
Volume3.27M
52 Week high$23.40
52 Week high$23.40
52 Week low$3.52
52 Week low$3.52
CAPR News
Simply Wall St 3d
Here's Why We Think Capricor Therapeutics, Inc.'s CEO Compensation Looks FairAdvertisement Key Insights Capricor Therapeutics to hold its Annual General Meeting on 22nd of May CEO Linda Marbán's total compensation includes salary of U...
TipRanks 3d
Capricor Therapeutics’ Earnings Call: Optimism Amid ChallengesCapricor Therapeutics, Inc. ((CAPR)) has held its Q1 earnings call. Read on for the main highlights of the call. Confident Investing Starts Here: Quickly and...
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own CAPR. This list is generated using Robinhood data, and it’s not a recommendation.